Eisai Limited announces the official opening of its new Canadian headquarters in Mississauga.
Eisai Limited announces the official opening of its new Canadian headquarters in Mississauga, which will play a key role in supporting the expansion of Eisai Limited's geographical and patient reach.
"Our new office represents a commitment to growing our business and increasing Eisai's presence here in Canada," said Oliver Technow, President and General Manager, Eisai Limited. "Eisai selected Mississauga for its Canadian headquarters due to its central location within the GTA, the largest economic cluster in Canada and a region well-known for its diverse and highly educated talent pool."
Eisai Limited was established on April 1, 2010, as the Canadian subsidiary of Eisai Inc., the U.S. pharmaceutical operating company of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai's global human health care (hhc) mission is to give first thought to patients and their families, and to increasing the benefits health care provides. As part of this mission, Eisai Limited is dedicated to a tradition of genuine concern for people and is driven by the desire to meet the diverse healthcare needs of patients, their families and caregivers. A key component to realizing this mission is to provide treatments, whenever possible, that address significant unmet medical needs.
"Over the past four years we have had tremendous success. We see potential for more opportunities to grow our team and to continue with our mission of putting patients first by providing medicines that help improve the lives of patients and their families," said Technow. "It is an exciting time for the organization and we look forward to continuing our success in Canada."